Related Experiment Videos
Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production?
1Biochemistry Department, Fremantle Hospital, Western Australia.
Aims:
To examine the potential role of the lipolytic enzyme phospholipase A2, produced by Helicobacter pylori in ulcer formation.
Methods:
Phospholipase A2 activity in H pylori was compared with that in 10 commonly occurring pathogenic bacteria. Phospholipase A2 activity and its cytotoxic metabolite, lysolecithin, in the basal gastric aspirates of 12 patients infected with H pylori were compared with those in 12 subjects not infected with H pylori.
Results:
The phospholipase A2 activity in H pylori was substantially higher than that in most of the other bacteria tested, and the activities of phospholipase A2 and lysolecithin in the basal gastric aspirates of those infected with H pylori were significantly higher than the activities found in the basal gastric aspirates of subjects who were not infected. The lysolecithin proportion of total phospholipids in the gastric aspirates was also much higher in the infected than the non-infected group and a weak positive correlation (0.415) was found between phospholipase A2 and lysolecithin in the infected group.
Conclusions:
H pylori has clinically important concentrations of phospholipase A2, an enzyme capable of hydrolysing gastric mucosal phospholipids. The high values of phospholipase A2 and lysolecithin in gastric fluid from subjects with H pylori infections supports the notion that phospholipase A2 is involved in the inflammation and mucosal damage associated with peptic ulcer formation.
Insights
Helicobacter pylori produces high levels of phospholipase A2, an enzyme linked to peptic ulcer formation. This enzyme and its byproduct, lysolecithin, are elevated in infected individuals, contributing to gastric damage.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Helicobacter pylori is a common pathogen associated with peptic ulcer disease.
- The role of bacterial enzymes in ulcer pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the role of phospholipase A2 (PLA2) produced by H. pylori in the development of gastric ulcers.
- To compare PLA2 activity in H. pylori with other pathogenic bacteria.
Main Methods:
- Assessed PLA2 activity in H. pylori and 10 other pathogenic bacteria.
- Measured PLA2 activity and lysolecithin levels in gastric aspirates from H. pylori-infected patients and uninfected controls.
Main Results:
- H. pylori exhibited significantly higher PLA2 activity compared to most other bacteria tested.
- Elevated levels of PLA2 and lysolecithin were observed in gastric aspirates of H. pylori-infected individuals.
- A higher proportion of lysolecithin to total phospholipids was found in infected subjects, with a positive correlation between PLA2 and lysolecithin.
Conclusions:
- H. pylori produces clinically relevant concentrations of PLA2, an enzyme that can degrade gastric mucosal phospholipids.
- Elevated PLA2 and lysolecithin in infected individuals support their involvement in H. pylori-induced inflammation and mucosal damage, contributing to peptic ulcer formation.